Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

In the latest trading session, Amgen (AMGN) closed at $355.25, marking a -1.44% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Amgen Biotech Experience (ABE), a global initiative ...

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline ...

Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for patients in a phase 3 stomach cancer trial compared to chemotherapy alone, according to ...

Amgen focuses on discovering and manufacturing medicines for serious diseases across several therapeutic areas. It sells its products globally, reaching customers in more than 50 countries including ...

CytomX Therapeutics is shrinking its head count by 40% as the biotech regroups and looks at fresh ways to conserve cash. In order to focus its resources on its lead antibody-drug conjugate (ADC) and ...

BOSTON (CBS.MW) -- Biotechnology stocks were climbing in midday trading Friday, led by shares of No. 1 biotech firm Amgen. Shares of Amgen rose $1.23, or 1.9 percent, to $65.05. Clinical trial data ...

Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse portfolios. Amgen boasts one of the largest portfolios in the biotech industry with ...